Skip to content

13F-HR filed by TAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD filed this 13F-HR for the quarter ended 2024-09-30, filed 2025-02-13, with 10 holding rows worth $37,950,196.

Accession
0001395064-25-000030
Filed
2025-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 12 entries on the cover page, a total value of $37,950,196 stated on the cover page (in dollars after the unit check, H1), rows summing to $37,950,196 with VALUE read as dollars as filed, 13F file number 028-24938. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerTakeda Vaccines, Inc. 028-24939

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HILLEVAX INC43157M102COM6,724,000$11,834,640dollars as filed
WAVE LIFE SCIENCES LTD SHSY95308105Stock1,346,892$11,044,514dollars as filed
OVID THERAPEUTICS INC690469101COMMON STOCK7,531,996$8,887,755dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK515,619$1,799,510dollars as filed
EQUILLIUM INC29446K106COM1,824,977$1,514,731dollars as filed
Xilio Therapeutics Inc.98422T100COM1,475,121$1,162,395dollars as filed
AMERICAN WELL CORP03044L204COM CL A NEW77,733$736,913dollars as filed
TURNSTONE BIOLOGICS CORP90042W100COM895,824$498,974dollars as filed
RANI THERAPEUTICS HLDGS INC753018100CMN203,190$438,890dollars as filed
STANDARD BIOTOOLS INC34385P108COM16,515$31,874dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001395064-25-000030this filing2025-02-13acceptance time not in the bulk data set